Table 4. Main pharmacological activities identified in compound 4.
Activity | Inhibition of indicated activity (IC50, μM) a |
---|---|
TSLP production (NHBE) | 0.075 b |
PI3K (p110δ/p85α) | 0.233 |
DNA-PK | 0.348 |
MT3 (QR2) | 0.4 |
PDE6 | 0.58 |
PDE5 | 0.92 |
mTOR | 0.964 |
Yes | 2.386 |
Ftl4 | 3.132 |
TrkA | 3.232 |
Hck | 3.581 |
Lck | 3.330 |
PI3K (p120γ) | 4.782 |
a Except for TSLP, all IC50 activities are based on biochemical assays dose response curves with duplicate determinations for each concentration.
b Activity as indicated in Fig 5.